Trending
November 19, 2024 Kevin Krause Appointed CEO of ArrePAthNovember 14, 2024 myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma PatientsNovember 12, 2024 Avalo Therapeutics Closes $69.4 Million FinancingNovember 4, 2024 Cornucopian Capital Joins $20M Round for Archon BiosciencesOctober 30, 2024 Orthobond Appoints George Landau as EVP, Business Development and Commercialization
Featured
November 19, 2024
Kevin Krause Appointed CEO of ArrePAth
PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, Inc., an emerging biotechnology company focused on applying deep phenotypic... Read more »
November 14, 2024
myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma Patients
Boston-based myBiometry, which is developing a device to help patients with asthma and chronic obstructive pulmonary... Read more »
November 12, 2024
Avalo Therapeutics Closes $69.4 Million Financing
WAYNE, Pa. and ROCKVILLE, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical... Read more »
